Description
This funding opportunity announcement encourages Small Business Innovation Research (SBIR) applications from small business concerns that seek additional funding to support clinical trials for projects related to the mission and goals of the National Institute of Neurological Disorders and Stroke (NINDS). The projects may evaluate drugs, biologics, devices, or diagnostics, as well as surgical, behavioral, or rehabilitation therapies. The funding initiative aims to facilitate the transition of SBIR Phase II projects to the commercialization stage by promoting partnerships between NIH's SBIR/STTR awardees and third-party investors and/or strategic partners.
Key aspects of this opportunity include:
• Focus on products related to the mission and goals of NINDS
• Evaluation of various treatments, including drugs, biologics, devices, and diagnostics
• Facilitation of partnerships between NIH's SBIR/STTR awardees and third-party investors and/or strategic partners
• Requirement for a Commercialization Plan, including details on any independent third-party investor funding